DEFITELIO

Approval Id: 566162f8f12006c3
Drug Approval Canada Name: DEFITELIO
Product Name: DEFITELIO
Status: Marketed
Status Date: 2017-09-06
Original Market Date: 2017-09-06
Din: 02465981
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 20:12.20
Atc Original: B01AX01 DEFIBROTIDE
Atc Name: b 01 ax 01
Aig Number: 0159250001
Company Name: JAZZ PHARMACEUTICALS IRELAND LIMITED
Company Address: 5th Floor, Waterloo Exchange, Waterloo Rd., Dublin, Dublin, Ireland, D04 E5W7
Company Detail Path: /organization/jazz-pharmaceuticals-ireland-limited

DEFIBROTIDE

80 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

566162f8f12006c3

Type

Standard